Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Raily Aesthetic Medicine International Holdings has a current ratio of 0.77. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Raily Aesthetic Medicine International Holdings has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
HKSE:02135's Current Ratio is ranked worse than 82.11% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 1.46
vs HKSE:02135: 0.77
Raily Aesthetic Medicine International Holdings (HKSE:02135) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Raily Aesthetic Medicine International Holdings Current Ratio Related Terms
Raily Aesthetic Medicine International Holdings Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raily Aesthetic Medicine International Holdings Current Ratio Chart
Raily Aesthetic Medicine International Holdings Annual Data
HKSE:02135 vs HCA, THC, DVA: Current Ratio Comparison
For the Medical Care Facilities subindustry, Raily Aesthetic Medicine International Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raily Aesthetic Medicine International Holdings Current Ratio vs Healthcare Providers & Services Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raily Aesthetic Medicine International Holdings (HKSE:02135) has a Current Ratio of 0.77 as of Dec. 2025. This is 10% below median its historical median of 0.86. Over the past decade, Raily Aesthetic Medicine International Holdings' Current Ratio has ranged from 0.53 to 2.68. According to the industry distribution chart, Raily Aesthetic Medicine International Holdings ranks #560 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 82.1%.
Is Raily Aesthetic Medicine International Holdings' Current Ratio too high?
Raily Aesthetic Medicine International Holdings' current Current Ratio of 0.77 is 10% below median its 10-year median of 0.86. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 2.68. The Healthcare Providers & Services industry median Current Ratio is 1.46. Raily Aesthetic Medicine International Holdings' value of 0.77 is 47.3% below this industry median. Based on the distribution chart, Raily Aesthetic Medicine International Holdings ranks #560 out of 682 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Raily Aesthetic Medicine International Holdings has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raily Aesthetic Medicine International Holdings' Current Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raily Aesthetic Medicine International Holdings ranks #560 out of 682 companies for Current Ratio. This places Raily Aesthetic Medicine International Holdings in the lower half of its industry. The industry median Current Ratio is 1.46. Raily Aesthetic Medicine International Holdings' value of 0.77 is 47.3% below this benchmark. Historically, Raily Aesthetic Medicine International Holdings' own Current Ratio has ranged from 0.53 to 2.68 over the past decade. While the company's 10-year median is 0.86 vs. the industry median of 1.46, Raily Aesthetic Medicine International Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.46, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raily Aesthetic Medicine International Holdings's current Current Ratio of 0.77 is 47.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raily Aesthetic Medicine International Holdings's current Current Ratio is 0.77, which is 10% below median its own 10-year median of 0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raily Aesthetic Medicine International Holdings stock overvalued right now?
Based on GuruFocus' analysis, Raily Aesthetic Medicine International Holdings (HKSE:02135) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.12 — trading 15% below its estimated fair value. The current Current Ratio is 0.77, which is 10% below median its 10-year median of 0.86 and 47.3% below the Healthcare Providers & Services industry median of 1.46. Raily Aesthetic Medicine International Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Raily Aesthetic Medicine International Holdings (HKSE:02135), the current Current Ratio is 0.77 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raily Aesthetic Medicine International Holdings (HKSE:02135) Overvalued in 2026?
Based on GuruFocus' analysis, Raily Aesthetic Medicine International Holdings stock appears to be undervalued.
The current stock price of HK$0.12 is trading 15% below its estimated GF Value™ of HK$0.14.
GuruFocus considers Raily Aesthetic Medicine International Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:02135:
Current Ratio: 0.77 (10% below median its 10-year median of 0.86)
GF Value™: HK$0.14 vs. price of HK$0.12 (15% below fair value)
Industry Position: 47.3% below the Healthcare Providers & Services median (#560 of 682)
No single metric tells the full story. See the HKSE:02135 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raily Aesthetic Medicine International Holdings Ltd is an investment holding company. The company were principally engaged in the provision of aesthetic medical services, sale of aesthetic medical equipment products and provision of consulting services. The group is organized into three reportable operating segments namely Aesthetic medical services comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology service and others; Aesthetic medical equipment products comprise principally sales of collagen injection products, surgical implants and aesthetic medical skincare products; Consulting services comprise principally management consulting services of which majority of revenue comes from Aesthetic medical services.
47GF Score
Get the complete analysis for HKSE:02135
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02135 has been successfully added to your 
